Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Arginine-rhamnosylation as new strategy to activate translation elongation factor P

  • Jürgen Lassak
  • , Eva C. Keilhauer
  • , Maximilian Fürst
  • , Kristin Wuichet
  • , Julia Gödeke
  • , Agata L. Starosta
  • , Jhong Min Chen
  • , Lotte Søgaard-Andersen
  • , Jürgen Rohr
  • , Daniel N. Wilson
  • , Susanne Häussler
  • , Matthias Mann
  • , Kirsten Jung

Producción científica: Articlerevisión exhaustiva

113 Citas (Scopus)

Resumen

Ribosome stalling at polyproline stretches is common and fundamental. In bacteria, translation elongation factor P (EF-P) rescues such stalled ribosomes, but only when it is post-translationally activated. In Escherichia coli, activation of EF-P is achieved by (R)-Î 2-lysinylation and hydroxylation of a conserved lysine. Here we have unveiled a markedly different modification strategy in which a conserved arginine of EF-P is rhamnosylated by a glycosyltransferase (EarP) using dTDP-L-rhamnose as a substrate. This is to our knowledge the first report of N-linked protein glycosylation on arginine in bacteria and the first example in which a glycosylated side chain of a translation elongation factor is essential for function. Arginine-rhamnosylation of EF-P also occurs in clinically relevant bacteria such as Pseudomonas aeruginosa. We demonstrate that the modification is needed to develop pathogenicity, making EarP and dTDP-L-rhamnose-biosynthesizing enzymes ideal targets for antibiotic development.

Idioma originalEnglish
Páginas (desde-hasta)266-270
Número de páginas5
PublicaciónNature Chemical Biology
Volumen11
N.º4
DOI
EstadoPublished - abr 1 2015

Nota bibliográfica

Publisher Copyright:
© 2015 Nature America, Inc. All rights reserved.

Financiación

We would like to thank I. Weitl for excellent technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft: Center for Integrated Protein Science Munich (CiPSM; Exc114/2 to K.J. and WI3285/4-1 to D.N.W.) and the Max Planck Society (to E.C.K., K.W., L.S.-A. and M.M.). A.L.S. is funded by an AXA Research Fund Postdoctoral Fellowship. The work of S.H. and J.G. was supported by the Helmholtz Association and the Bundesministerium für Bildung und Forschung. J.-M.C. and J.R are funded by the US National Institutes of Health (CA 091901).

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)CA 091901
National Institute of General Medical SciencesR01GM105977
Deutsche ForschungsgemeinschaftExc114/2, WI3285/4-1
AXA Research Fund
Bundesministerium für Bildung und Forschung
Fritz-Haber-Institut der Max-Planck-Gesellschaft
Max Delbrück Center for Molecular Medicine in the Helmholtz Association

    ASJC Scopus subject areas

    • Molecular Biology
    • Cell Biology

    Huella

    Profundice en los temas de investigación de 'Arginine-rhamnosylation as new strategy to activate translation elongation factor P'. En conjunto forman una huella única.

    Citar esto